Matusiewicz R, Urbankowska B, Kowalczyk M
Oddział Chorób Wewnetrznych Szpitala Grochowskiego, Warszawie.
Pneumonol Alergol Pol. 1991;59(11-12):31-4.
The study was carried out in 40 patients with atopic asthma, age 16-31 years (mean 26 years) and 30 healthy volunteers, age 19-25 years (mean 20 years). In vivo granulocyte migration tests were carried out simultaneously using two methods: Southam's and the authors' original (Matusiewicz, Brzezińska). The above mentioned tests were carried out twice: the first time in December/January, the second time February/March after subcutaneous administration of PAF. The authors have demonstrated that in patients with atopic asthma a defect in migration of tissue granulocytes is present. They have also shown that PAF does not effect significantly granulocyte migration in atopic patients.
该研究对40例年龄在16至31岁（平均26岁）的特应性哮喘患者和30例年龄在19至25岁（平均20岁）的健康志愿者进行。采用两种方法同时进行体内粒细胞迁移试验：索瑟姆法和作者原创的方法（马图谢维茨、布热津斯卡法）。上述试验进行了两次：第一次在12月/1月，第二次在皮下注射血小板活化因子（PAF）后的2月/3月。作者已证明，特应性哮喘患者存在组织粒细胞迁移缺陷。他们还表明，PAF对特应性患者的粒细胞迁移没有显著影响。
